X-linked agammaglobulinemia epidemiology and demographics

X-linked agammaglobulinemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating X-linked agammaglobulinemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Serology
Chest X Ray
CT
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
X-linked agammaglobulinemia epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of X-linked agammaglobulinemia epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on X-linked agammaglobulinemia epidemiology and demographics
CDC on X-linked agammaglobulinemia epidemiology and demographics
X-linked agammaglobulinemia epidemiology and demographics in the news
Blogs on X-linked agammaglobulinemia epidemiology and demographics
Directions to Hospitals Treating X-linked agammaglobulinemia
Risk calculators and risk factors for X-linked agammaglobulinemia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Epidemiology and Demographics

XLA is an X-linked disorder, and therefore is almost always limited to males. It occurs in a frequency of about 1 in 100,000 male newborns, and has no ethnic predisposition.